Cargando…

Hyaluronan activated-metabolism phenotype (HAMP) in pancreatic ductal adenocarcinoma

Background: The aggressiveness of pancreatic ductal adenocarcinoma (PDAC) is enhanced by its interactions with stromal extracellular matrix, notably with hyaluronan (HA). Our previous studies have demonstrated increased expression of genes involved in HA synthesis and degradation in PDAC, suggesting...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kudo, Yuzan, Kohi, Shiro, Hirata, Keiji, Goggins, Michael, Sato, Norihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771457/ https://www.ncbi.nlm.nih.gov/pubmed/31608136 http://dx.doi.org/10.18632/oncotarget.27172

Ejemplares similares

Prognostic and functional role of hyaluronan-binding protein 1 in pancreatic ductal adenocarcinoma
por: Adachi, Yasuhiro, et al.
Publicado: (2022)

Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinoma
por: Sato, Norihiro, et al.
Publicado: (2016)

Role of hyaluronan in pancreatic cancer biology and therapy: Once again in the spotlight
por: Sato, Norihiro, et al.
Publicado: (2016)

Prognostic Impact of Hyaluronan and Its Regulators in Pancreatic Ductal Adenocarcinoma
por: Cheng, Xiao-Bo, et al.
Publicado: (2013)

Hyaluronan stimulates pancreatic cancer cell motility
por: Cheng, Xiao-Bo, et al.
Publicado: (2015)

Receptor for Hyaluronic Acid-Mediated Motility is Associated with Poor Survival in Pancreatic Ductal Adenocarcinoma
por: Cheng, Xiao-Bo, et al.
Publicado: (2015)

Hypoxia increases KIAA1199/CEMIP expression and enhances cell migration in pancreatic cancer
por: Oba, Takuya, et al.
Publicado: (2021)

KIAA1199 is induced by inflammation and enhances malignant phenotype in pancreatic cancer
por: Kohi, Shiro, et al.
Publicado: (2017)

4-Methylumbelliferone inhibits enhanced hyaluronan synthesis and cell migration in pancreatic cancer cells in response to tumor-stromal interactions
por: Cheng, Xiao-Bo, et al.
Publicado: (2018)

Triple bypass for advanced pancreatic head cancer associated with biliary stricture, duodenal stenosis, and recurrent obstructive pancreatitis
por: Kudo, Yuzan, et al.
Publicado: (2016)

An advanced bipolar device helps reduce the rate of postoperative pancreatic fistula in laparoscopic gastrectomy for gastric cancer patients: a propensity score-matched analysis
por: Shibao, Kazunori, et al.
Publicado: (2022)

Hyaluromycin, a Novel Hyaluronidase Inhibitor, Attenuates Pancreatic Cancer Cell Migration and Proliferation
por: Kohi, Shiro, et al.
Publicado: (2016)

The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma
por: Kudo, Daisuke, et al.
Publicado: (2017)

Is hyaluronan deposition in the stroma of pancreatic ductal adenocarcinoma of prognostic significance?
por: Gebauer, Florian, et al.
Publicado: (2017)

Non-Invasive Monitoring of Stromal Biophysics with Targeted Depletion of Hyaluronan in Pancreatic Ductal Adenocarcinoma
por: Maloney, Ezekiel, et al.
Publicado: (2019)

Hamp1 but not Hamp2 regulates ferroportin in fish with two functionally distinct hepcidin types
por: Neves, João V., et al.
Publicado: (2017)

Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas
por: Handra-Luca, A, et al.
Publicado: (2011)

Metabolism remodeling in pancreatic ductal adenocarcinoma
por: Li, Jin-Tao, et al.
Publicado: (2019)

Time to progression of pancreatic ductal adenocarcinoma from low-to-high tumour stages
por: Yu, Jun, et al.
Publicado: (2015)

Biological and Clinical Impacts of Glucose Metabolism in Pancreatic Ductal Adenocarcinoma
por: Liu, Zhao, et al.
Publicado: (2023)

Image-Based Molecular Phenotyping of Pancreatic Ductal Adenocarcinoma
por: Kaissis, Georgios A., et al.
Publicado: (2020)

Non-Invasive Monitoring of Increased Fibrotic Tissue and Hyaluronan Deposition in the Tumor Microenvironment in the Advanced Stages of Pancreatic Ductal Adenocarcinoma
por: Vohra, Ravneet, et al.
Publicado: (2022)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

Obstructive Sleep Apnea and Pathological Characteristics of Resected Pancreatic Ductal Adenocarcinoma
por: Dal Molin, Marco, et al.
Publicado: (2016)

The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma
por: Melendez-Zajgla, Jorge, et al.
Publicado: (2021)

Markers of Bone Metabolism in Patients With Chronic Pancreatitis and Pancreatic Ductal Adenocarcinoma
por: Pezzilli, Raffaele, et al.
Publicado: (2015)

Fibrosis-related miRNAs as serum biomarkers for pancreatic ductal adenocarcinoma
por: Suzuki, Rei, et al.
Publicado: (2017)

Changes in operative trends and short‐term outcomes of surgery for congenital biliary dilatation in adults using real‐world data: A multilevel analysis based on a nationwide administrative database in Japan
por: Mori, Yasuhisa, et al.
Publicado: (2022)

The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
por: Wang, Lai Mun, et al.
Publicado: (2015)

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
por: Ghosh, Chandrayee, et al.
Publicado: (2019)

Key drug-targeting genes in pancreatic ductal adenocarcinoma
por: Sakharkar, Meena Kishore, et al.
Publicado: (2021)

CTC phenotyping for a preoperative assessment of tumor metastasis and overall survival of pancreatic ductal adenocarcinoma patients
por: Sun, Yukun, et al.
Publicado: (2019)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

Dissecting cell-type-specific metabolism in pancreatic ductal adenocarcinoma
por: Lau, Allison N, et al.
Publicado: (2020)

Targets (Metabolic Mediators) of Therapeutic Importance in Pancreatic Ductal Adenocarcinoma
por: Rai, Vikrant, et al.
Publicado: (2020)

Molecular and Metabolic Subtypes Correspondence for Pancreatic Ductal Adenocarcinoma Classification
por: Espiau-Romera, Pilar, et al.
Publicado: (2020)

Ubiquitous Aberration in Cholesterol Metabolism across Pancreatic Ductal Adenocarcinoma
por: Gunda, Venugopal, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3pee7nk795mpaota12acd4k7be